277 related articles for article (PubMed ID: 34997041)
1. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
[TBL] [Abstract][Full Text] [Related]
2. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
4. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
[TBL] [Abstract][Full Text] [Related]
5. Vaccine protection against Zika virus from Brazil.
Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice.
Pardy RD; Rajah MM; Condotta SA; Taylor NG; Sagan SM; Richer MJ
PLoS Pathog; 2017 Feb; 13(2):e1006184. PubMed ID: 28231312
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
[TBL] [Abstract][Full Text] [Related]
8. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
9. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells promote humoral immunity and viral control during Zika virus infection.
Elong Ngono A; Young MP; Bunz M; Xu Z; Hattakam S; Vizcarra E; Regla-Nava JA; Tang WW; Yamabhai M; Wen J; Shresta S
PLoS Pathog; 2019 Jan; 15(1):e1007474. PubMed ID: 30677097
[TBL] [Abstract][Full Text] [Related]
11. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
[TBL] [Abstract][Full Text] [Related]
12. Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins.
Mirza MU; Rafique S; Ali A; Munir M; Ikram N; Manan A; Salo-Ahen OM; Idrees M
Sci Rep; 2016 Dec; 6():37313. PubMed ID: 27934901
[TBL] [Abstract][Full Text] [Related]
13. Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an
Ganji M; Bakhshi S; Ahmadi K; Shoari A; Moeini S; Ghaemi A
J Biomol Struct Dyn; 2024 Apr; 42(7):3426-3440. PubMed ID: 37190978
[TBL] [Abstract][Full Text] [Related]
14. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
15. Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection.
Tarbe M; Dong W; Hu G; Xu Y; Sun J; Grayo S; Chen X; Qin C; Zhao J; Liu L; Li X; Leng Q
Front Immunol; 2020; 11():577546. PubMed ID: 33101303
[TBL] [Abstract][Full Text] [Related]
16. CD8
Huang H; Li S; Zhang Y; Han X; Jia B; Liu H; Liu D; Tan S; Wang Q; Bi Y; Liu WJ; Hou B; Gao GF; Zhang F
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835502
[TBL] [Abstract][Full Text] [Related]
17. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
[TBL] [Abstract][Full Text] [Related]
18. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
[TBL] [Abstract][Full Text] [Related]
20. Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine.
Karkashan A
Front Immunol; 2024; 15():1395870. PubMed ID: 38799422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
